Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review

Infection

Volumn 42, Issue 5, 2014, Pages 801-809

  Bargiacchi, O ^a   Rossati, A ^a   Car, P ^a   Brustia, D ^a   Brondolo, R ^a   Rosa, F ^a   Garavelli, P L ^a   De Rosa, F G ^b  

^a UNIVERSITY HOSPITAL MAGGIORE DELLA CARITÀ   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Intrathecal colistin; Multidrug resistant Gram negative infections; Nosocomial meningitis; Ventriculitis

Indexed keywords

ANTIINFECTIVE AGENT; COLISTIN;

ADOLESCENT; ADULT; ADVERSE EFFECTS; CASE REPORT; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; CROSS INFECTION; DRUG EFFECTS; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE AEROBIC RODS AND COCCI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE;

EID: 84918818938     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0618-0     Document Type: Review

References (62)

1. Jantzen JP. Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol. 2007;21:517–38.
2. Gutiérrez-González R, Boto GR, Pérez-Zamarrón A. Cerebrospinal fluid diversion devices and infection. A comprehensive review. Eur J Clin Microbiol Infect Dis. 2012;31:889–97.
3. Kim JH, Desai NS, Ricci J, Stieg PE, Rosengart AJ, Härtl R, Fraser JF. Factors contributing to ventriculostomy infection. World Neurosurg. 2012;77:135–40.
4. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II group of investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.
5. Stenehjem E, Armstrong WS. Central nervous system device infections. Infect Dis Clin North Am. 2012;26:89–110.
6. Camacho EF, Boszczowski I, Basso M, Jeng BC, Freire MP, Guimarães T, Teixeira MJ, Costa SF. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47–51.
7. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–41.
8. Price DJ, Sleigh JD. Klebsiella meningitis—report of nine cases. J Neurol Neurosurg Psychiatry. 1972;35:903–8.
9. Kaplan SL, Patrick CC. Cefotaxime and aminoglycoside treatment of meningitis caused by Gram-negative enteric organisms. Pediatr Infect Dis J. 1990;9:810–4.
10. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis. 1999;28:916–7.
11. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol. 2000;38:3523.
12. Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother. 2004;54:290–2.
13. Quinn AL, Parada JP, Belmares J, O’Keefe JP. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother. 2005;39:949–52.
14. Suárez Fernández C, Fernández-Viladrich P, Tubau F, Corral L, Mateu A. Intrathecal colistin treatment of central nervous system infections due to multi-resistant Acinetobacter baumannii. In: Program and Abstracts of 15th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number 1134_02_277. Copenhagen
15. Gump WC, Walsh JW. Intrathecal colistin for treatment of highly resistant pseudomonas ventriculitis. case report and review of the literature. J Neurosurg. 2005;102:915.
16. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348–52.
17. Bukhary Z, Mahmood W, Al-Khani A, Al-Abdely HM. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi Med J. 2005;26:656–8.
18. Sueke H, Marsh H, Dhital A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg. 2005;19:51–2.
19. Berlana D, Llop JM, Fort E, Badia MB, Jódar R. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am J Health Syst Pharm. 2005;62:39–47.
20. Charra B, Hachimi A, Benslama A, Motaouakkil S. Intrathecal use of colistin. Ann Fr Anesth Reanim. 2006;25:215.
21. Karakitsos D, Paramythiotou E, Samonis G, Karabinis A. Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand. 2006;50:1309–10.
22. Yagmur R, Esen F. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome. Crit Care. 2006;10:428.
23. Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother. 2006;58:1078–81.
24. Al Shirawi N, Memish ZA, Cherfan A, Al Shimemeri A. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. J Chemother. 2006;18:554–8.
25. Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M. Colistin and rifampin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect. 2006;53:274–8.
26. Schina M, Spyridi E, Daoudakis M, Mertzanos E, Korfias S. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis. 2006;10:178–9.
27. Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007;60:197–9.
28. Enfanto CM, Shin S. Treatment with intrathecal colistin of a resistant extended-spectrum [beta]-lactamase-producing Klebsiella pneumoniae in the cerebrospinal fluid. Infect Dis Clin Pract. 2007;15:274–7.
29. Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect. 2007;40:537–40.
30. Paramythiotou E, Karakitsos D, Aggelopoulou H, Sioutos P, Samonis G, Karabinis A. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect. 2007;37:124–5.
31. Lee CH, Tang YF, Su LH, Chien CC, Liu JW. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb Drug Resist. 2008;14:233–7.
32. Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008;61:908–13.
33. Hachimi A, Charra B, Benslama A, Motaouakkil S. Intrathecal use of amikacin and colistin. Ann Fr Anesth Reanim. 2008;27:113–4.
34. Rodriguez CH, Bombicino K, Granados G, Nastro M, Vay C, Famiglietti A. Selection of colistin-resistant Acinetobacter baumannii isolates in post neurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis. 2009;65:188–91.
35. López-Alvarez B, Martín-Láez R, Fariñas MC, Paternina-Vidal B, García-Palomo JD, Vázquez-Barquero A. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir (Wien). 2009;151:1465–72.
36. Dalgic N, Ceylan Y, Sancar M, Telhan L, Kafadar I, Cavusoglu H, Ceylan O, Hasim O. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Ann Trop Paediatr. 2009;29:141–7.
37. Baiocchi M, Catena V, Zago S, Badolati L, Baccarin M. Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after eurosurgical ventriculitis. Infez Med. 2010;18:182–6.
38. De Pascale G, Pompucci A, Maviglia R, Spanu T, Bello G, Mangiola A, Scoppettuolo G. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin. Minerva Anestesiol. 2010;76:957–60.
39. Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect. 2010;16:888–94.
40. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M, David A. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 2010;14:e572–9.
41. Kim K, Kang HS, Sohn CH, Oh BM. Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis. Acta Neurochir (Wien). 2011;153:425–7.
42. Ozdemir H, Tapisiz A, Ciftçi E, Ince E, Mokhtari H, Güriz H, Aysev AD, Doğru U. Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis. Infection. 2010;38:241–4.
43. Razmkon A, Mehrafshan A, Bakhtazad A. Management of post-neurosurgical Acinetobacter infections: experiences obtained during an outbreak. Acta Neurochir (Wien). 2011;153:435–6.
44. Patel JA, Pacheco SM, Postelnick M, Sutton S. Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis. Am J Health Syst Pharm. 2011;68:1527–31.
45. Saleem AF, Shah MS, Shaikh AS, Mir F, Zaidi AK. Acinetobacter species meningitis in children: a case series from Karachi. Pak J Infect Dev Ctries. 2011;5:809–14.
46. Alaoui SY, Nejmi SE, Chakir AA, Hmamouchi B, Chlilek A. Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumanii. Ann Fr Anesth Reanim. 2011;30:854–5.
47. Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, Wang JH, Chi CY, Ho MW. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect. 2012. doi:10.1016/j.jmii.2012.08.028.
48. Imberti R, Cusato M, Accetta G, Marinò V, Procaccio F, Del Gaudio A, Iotti GA, Regazzi M. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother. 2012;56:4416–21.
49. Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother. 2013;57:1938–40.
50. Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents. 2013;41:480–3.
51. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84.
52. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–50.
53. Liang W, Liu XF, Huang J, Zhu DM, Li J, Zhang J. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. BMC Infect Dis. 2011;27:109.
54. Tan TY, Lim TP, Lee WH, Sasikala S, Hsu LY, Kwa AL. In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and E test methods. Antimicrob Agents Chemother. 2011;55:436–8.
55. Tascini C, Gemignani G, Ferranti S, Tagliaferri E, Leonildi A, Lucarini A, Menichetti F. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J Chemother. 2004;16:282–7.
56. Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, Lewis R, Ferranti S, Rossolini GM, Menichetti F. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:3990–3.
57. Jiménez-Mejías ME, Pichardo-Guerrero C, Márquez-Rivas FJ, Martín-Lozano D, Prados T, Pachón J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis. 2002;21:212–4.
58. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53:3430–6.
59. Everett ED, Strausbaugh LJ. Antimicrobial agents and the central nervous system. Neurosurgery. 1980;6:691–714.
60. Jiménez-Mejías ME, Becerril B, Márquez-Rivas FJ, Pichardo C, Cuberos L, Pachón J. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Infect Dis. 2000;19:970–1.
61. Antachopoulos C, Karvanen M, Iosifidis E, Jansson B, Plachouras D, Cars O, Roilides E. Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agents Chemother. 2010;54:3985–7.
62. Markantonis SL, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I, Dimopoulou E, Baltopoulos G. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother. 2009;53:4907–10.